Filtros : "PESSOA JUNIOR, ADALBERTO" "Financiamento ANID" Removido: "Process Biochemistry" Limpar

Filtros



Refine with date range


  • Source: International Journal of Molecular Sciences. Unidade: FCF

    Subjects: LEUCEMIA, PROTEÍNAS RECOMBINANTES

    Versão PublicadaAcesso à fonteDOIHow to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
    • ABNT

      PEDROSO, Alejandro et al. Toward Safer Biotherapeutics: Expression and Characterization of a Humanized Chimeric L-Asparaginase in E. coli. International Journal of Molecular Sciences, v. 26, n. 14, p. 1-29 art. 6919, 2025Tradução . . Disponível em: https://dx.doi.org/10.3390/ijms26146919. Acesso em: 27 nov. 2025.
    • APA

      Pedroso, A., Miranda, J., Lefin, N., Effer, B., Reyanldo, E. P., Calle, Y., et al. (2025). Toward Safer Biotherapeutics: Expression and Characterization of a Humanized Chimeric L-Asparaginase in E. coli. International Journal of Molecular Sciences, 26( 14), 1-29 art. 6919. doi:10.3390/ijms26146919
    • NLM

      Pedroso A, Miranda J, Lefin N, Effer B, Reyanldo EP, Calle Y, Monteiro G, Pessoa Junior A, Farías JG. Toward Safer Biotherapeutics: Expression and Characterization of a Humanized Chimeric L-Asparaginase in E. coli [Internet]. International Journal of Molecular Sciences. 2025 ; 26( 14): 1-29 art. 6919.[citado 2025 nov. 27 ] Available from: https://dx.doi.org/10.3390/ijms26146919
    • Vancouver

      Pedroso A, Miranda J, Lefin N, Effer B, Reyanldo EP, Calle Y, Monteiro G, Pessoa Junior A, Farías JG. Toward Safer Biotherapeutics: Expression and Characterization of a Humanized Chimeric L-Asparaginase in E. coli [Internet]. International Journal of Molecular Sciences. 2025 ; 26( 14): 1-29 art. 6919.[citado 2025 nov. 27 ] Available from: https://dx.doi.org/10.3390/ijms26146919
  • Source: Fermentation. Unidade: FCF

    Subjects: ESCHERICHIA COLI, AMINOÁCIDOS, ENZIMAS

    Versão PublicadaAcesso à fonteDOIHow to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
    • ABNT

      LEFIN, Nicolás et al. Optimized amino acid-enhanced medium for efficient L-Asparaginase II production in E. coli: from shake flask to bioreactor. Fermentation, v. 11, p. 1-27 art. 239, 2025Tradução . . Disponível em: https://dx.doi.org/10.3390/fermentation11050239. Acesso em: 27 nov. 2025.
    • APA

      Lefin, N., Miranda, J., Costa, I. M., Reynaldo, A. P., Monteiro, G., Zamorano, M., et al. (2025). Optimized amino acid-enhanced medium for efficient L-Asparaginase II production in E. coli: from shake flask to bioreactor. Fermentation, 11, 1-27 art. 239. doi:10.3390/fermentation11050239
    • NLM

      Lefin N, Miranda J, Costa IM, Reynaldo AP, Monteiro G, Zamorano M, Pessoa Junior A, Farías JG. Optimized amino acid-enhanced medium for efficient L-Asparaginase II production in E. coli: from shake flask to bioreactor [Internet]. Fermentation. 2025 ; 11 1-27 art. 239.[citado 2025 nov. 27 ] Available from: https://dx.doi.org/10.3390/fermentation11050239
    • Vancouver

      Lefin N, Miranda J, Costa IM, Reynaldo AP, Monteiro G, Zamorano M, Pessoa Junior A, Farías JG. Optimized amino acid-enhanced medium for efficient L-Asparaginase II production in E. coli: from shake flask to bioreactor [Internet]. Fermentation. 2025 ; 11 1-27 art. 239.[citado 2025 nov. 27 ] Available from: https://dx.doi.org/10.3390/fermentation11050239
  • Source: Algal Research. Unidade: FCF

    Subjects: MUTAGÊNESE, ANTIOXIDANTES

    PrivadoAcesso à fonteDOIHow to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
    • ABNT

      MUSSAGY, Cassamo Ussemane et al. Comparative analysis of bacterial and microalgal natural astaxanthin: Part II — Biocompatibility, bioaccessibility, encapsulation, mutagenicity, and aquatic toxicity. Algal Research, v. 91, p. 1-11 art. 104343, 2025Tradução . . Disponível em: https://dx.doi.org/10.1016/j.algal.2025.104343. Acesso em: 27 nov. 2025.
    • APA

      Mussagy, C. U., Gini, A. L. R., Scarim, C. B., Duarte, J. L., Chorilli, M., Militao, G. F. G., et al. (2025). Comparative analysis of bacterial and microalgal natural astaxanthin: Part II — Biocompatibility, bioaccessibility, encapsulation, mutagenicity, and aquatic toxicity. Algal Research, 91, 1-11 art. 104343. doi:10.1016/j.algal.2025.104343
    • NLM

      Mussagy CU, Gini ALR, Scarim CB, Duarte JL, Chorilli M, Militao GFG, Santos A dos, Lima NP, Ribeiro IS, Haminiuk CWI, Farias FO, Umbuzeiro G de A, Pessoa Junior A. Comparative analysis of bacterial and microalgal natural astaxanthin: Part II — Biocompatibility, bioaccessibility, encapsulation, mutagenicity, and aquatic toxicity [Internet]. Algal Research. 2025 ; 91 1-11 art. 104343.[citado 2025 nov. 27 ] Available from: https://dx.doi.org/10.1016/j.algal.2025.104343
    • Vancouver

      Mussagy CU, Gini ALR, Scarim CB, Duarte JL, Chorilli M, Militao GFG, Santos A dos, Lima NP, Ribeiro IS, Haminiuk CWI, Farias FO, Umbuzeiro G de A, Pessoa Junior A. Comparative analysis of bacterial and microalgal natural astaxanthin: Part II — Biocompatibility, bioaccessibility, encapsulation, mutagenicity, and aquatic toxicity [Internet]. Algal Research. 2025 ; 91 1-11 art. 104343.[citado 2025 nov. 27 ] Available from: https://dx.doi.org/10.1016/j.algal.2025.104343
  • Source: Preparative Biochemistry & Biotechnology. Unidade: FCF

    Subjects: TERMODINÂMICA, MEDICAMENTO

    PrivadoAcesso à fonteDOIHow to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
    • ABNT

      OBREQUE, Karin Mariana Torres et al. PEGylation versus glycosylation: effect on the thermodynamics and thermostability of crisantaspase. Preparative Biochemistry & Biotechnology, v. 54, n. 4, p. 503-513, 2024Tradução . . Disponível em: https://doi.org/10.1080/10826068.2023.2249100. Acesso em: 27 nov. 2025.
    • APA

      Obreque, K. M. T., Kleingesinds, E. K., Santos, J. H. P. M., Carretero, G. P. B., Cunha, J. R., Converti, A., et al. (2024). PEGylation versus glycosylation: effect on the thermodynamics and thermostability of crisantaspase. Preparative Biochemistry & Biotechnology, 54( 4), 503-513. doi:10.1080/10826068.2023.2249100
    • NLM

      Obreque KMT, Kleingesinds EK, Santos JHPM, Carretero GPB, Cunha JR, Converti A, Monteiro G, Pessoa Junior A, Rangel-Yagui C de O. PEGylation versus glycosylation: effect on the thermodynamics and thermostability of crisantaspase [Internet]. Preparative Biochemistry & Biotechnology. 2024 ; 54( 4): 503-513.[citado 2025 nov. 27 ] Available from: https://doi.org/10.1080/10826068.2023.2249100
    • Vancouver

      Obreque KMT, Kleingesinds EK, Santos JHPM, Carretero GPB, Cunha JR, Converti A, Monteiro G, Pessoa Junior A, Rangel-Yagui C de O. PEGylation versus glycosylation: effect on the thermodynamics and thermostability of crisantaspase [Internet]. Preparative Biochemistry & Biotechnology. 2024 ; 54( 4): 503-513.[citado 2025 nov. 27 ] Available from: https://doi.org/10.1080/10826068.2023.2249100
  • Source: Medical Oncology. Unidade: FCF

    Subjects: LEUCEMIA, ANTINEOPLÁSICOS

    Acesso à fonteDOIHow to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
    • ABNT

      PÉREZ, Maria Tosta et al. L-Asparaginase as the gold standard in the treatment of acute lymphoblastic leukemia: a comprehensive review. Medical Oncology, v. 40, n. 5, p. 1-15, 2023Tradução . . Disponível em: https://doi.org/10.1007/s12032-023-02014-9. Acesso em: 27 nov. 2025.
    • APA

      Pérez, M. T., Belén, L. H., Letelier, P., Calle, Y., Pessoa Junior, A., & Farías, J. G. (2023). L-Asparaginase as the gold standard in the treatment of acute lymphoblastic leukemia: a comprehensive review. Medical Oncology, 40( 5), 1-15. doi:10.1007/s12032-023-02014-9
    • NLM

      Pérez MT, Belén LH, Letelier P, Calle Y, Pessoa Junior A, Farías JG. L-Asparaginase as the gold standard in the treatment of acute lymphoblastic leukemia: a comprehensive review [Internet]. Medical Oncology. 2023 ; 40( 5): 1-15.[citado 2025 nov. 27 ] Available from: https://doi.org/10.1007/s12032-023-02014-9
    • Vancouver

      Pérez MT, Belén LH, Letelier P, Calle Y, Pessoa Junior A, Farías JG. L-Asparaginase as the gold standard in the treatment of acute lymphoblastic leukemia: a comprehensive review [Internet]. Medical Oncology. 2023 ; 40( 5): 1-15.[citado 2025 nov. 27 ] Available from: https://doi.org/10.1007/s12032-023-02014-9
  • Source: 3 Biotech. Unidade: FCF

    Subjects: VIRULÊNCIA, BIOINFORMÁTICA

    Acesso à fonteDOIHow to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
    • ABNT

      BELÉN, Lisandra Herrera et al. Helicobacter pylori l-asparaginase: a study of immunogenicity from an in silico approach. 3 Biotech, v. 12, p. 1-6 art. 286, 2022Tradução . . Disponível em: https://doi.org/10.1007/s13205-022-03359-0. Acesso em: 27 nov. 2025.
    • APA

      Belén, L. H., Beltrán, J. F., Pessoa Junior, A., Castillo, R. L., Rangel-Yagui, C. de O., & Farías, J. G. (2022). Helicobacter pylori l-asparaginase: a study of immunogenicity from an in silico approach. 3 Biotech, 12, 1-6 art. 286. doi:10.1007/s13205-022-03359-0
    • NLM

      Belén LH, Beltrán JF, Pessoa Junior A, Castillo RL, Rangel-Yagui C de O, Farías JG. Helicobacter pylori l-asparaginase: a study of immunogenicity from an in silico approach [Internet]. 3 Biotech. 2022 ; 12 1-6 art. 286.[citado 2025 nov. 27 ] Available from: https://doi.org/10.1007/s13205-022-03359-0
    • Vancouver

      Belén LH, Beltrán JF, Pessoa Junior A, Castillo RL, Rangel-Yagui C de O, Farías JG. Helicobacter pylori l-asparaginase: a study of immunogenicity from an in silico approach [Internet]. 3 Biotech. 2022 ; 12 1-6 art. 286.[citado 2025 nov. 27 ] Available from: https://doi.org/10.1007/s13205-022-03359-0

Digital Library of Intellectual Production of Universidade de São Paulo     2012 - 2025